Sun, Sand & Science

This activity will educate CV professionals throughout California, and build a community to refer and treat patients to yield better outcomes in various disease states.

Target Audience

This activity is intended for an audience of physicians.

Learning Objectives

  • Identify, treat and manage metabolic syndrome using appropriate guidelines and data.
  • Improve screening of patients for risk of heart disease to improve the management and treatment of patients at risk for CV disease.
  • Discuss platelet blocking agents.
  • Improve treatment of heart failure patients in an effort to improve patient outcomes for renal disease.
  • Integrate the use of inflammatory markers in the diagnosis, treatment and management of CAD.
  • Integrate appropriate tools to screen for depression; refer patients at risk to the appropriate caregiver.
  • Identify patients with sleep apnea and integrate treatment options in an effort to reduce potential heart failure caused by untreated sleep apnea.
  • Identify patients with Vitamin D deficiency and prescribe appropriate supplements.
  • Discuss food selection and preparation of foods with patients who are at risk for diabetes and heart disease.
  • Discuss smoking cessation strategies with patients who smoke in an effort to reduce CV risk.
  • Integrate data/research for appropriateness criteria as it relates to CCT and CMRI into their practice.
Course summary
Available credit: 
  • 8.00 ABIM Medical Knowledge
  • 8.00 AMA PRA Category 1 Credit
  • 8.00 Attendance
Course opens: 
05/01/2026
Course expires: 
12/31/2026
Cost:
$0.00
Rating: 
0
May 1 - 3, 2026 in Santa Barbara, CA
United States

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Reviewer(s)

Dorothy Caputo, MA BSN RN

has no relevant financial relationships to disclose at this time.

Amanda Dipasquale

has no relevant financial relationships to disclose at this time.
Speaker, Instructor, Faculty(s)

Bina Ahmed

has no relevant financial relationships to disclose at this time.

Sanjeev Bhavnani, MD FACC

has a financial relationship (Advisor) with Samsung Research America;.
has a financial relationship (Consultant) with Health Tecquity;.
has a financial relationship (Consultant) with CONNEQT Health;.
has a financial relationship (Consultant) with RCE.AI;.

David Cho, MD, MBA

has no relevant financial relationships to disclose at this time.

Christina Craigo, DNP MSN ACNP

has no relevant financial relationships to disclose at this time.

Teresa Daniele

has no relevant financial relationships to disclose at this time.

Imo Ebong

has a financial relationship (Advisor) with Alnylam;.
has a financial relationship (Advisor) with Bridgebio;.

Norman FACC

has no relevant financial relationships to disclose at this time.

Afshan Hameed

has no relevant financial relationships to disclose at this time.

John Harold, MD, MACC, MACP, FESC, FRCPI (Hon), FRCP (Hon), FICS (Hon), FIPC (Hon), FCSI, FIASC, FCCP, FAHA

has no relevant financial relationships to disclose at this time.

Melody Hermel, MD, FACC

has no relevant financial relationships to disclose at this time.

Jeffrey Hsu, MD, PhD, FAHA, FACC

has no relevant financial relationships to disclose at this time.

Tim Madden

has no relevant financial relationships to disclose at this time.

Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC

has a financial relationship (Individual stocks and stock options) with Elixir Medical, Stel, ControlRad (Spouse);.
has a financial relationship (Consultant) with Elixir Medical, IQVIA, Medtronic, Medscape/WebMD Global, NovoNordisk;.
has a financial relationship (Researcher) with Abbott, Alleviant Medical, Beth Israel Deaconess Medical Center, Concept Medical, CPC Clinical Research, Cordis, Elixir Medical, Faraday Pharmaceuticals, Idorsia Pharmaceuticals, Janssen, MedAlliance, Mediasphere Medical, Medtronic, Novartis, Protembis Gm;.

Mamoo Nakamura

has no relevant financial relationships to disclose at this time.

Purvi Parwani, MBBS MPH FACC

has a financial relationship (Consultant) with Edwards LifeScience;.
has a financial relationship (Speaker) with BMS;.
has a financial relationship (Speaker) with Zoll;.

Jamal Rana, MD, PhD, FACC

has no relevant financial relationships to disclose at this time.

Sion Roy

has a financial relationship (Individual stocks and stock options) with Heart Lung;.
has a financial relationship (Individual stocks and stock options) with Rhythm Science;.

Hilary Shapiro

has no relevant financial relationships to disclose at this time.

Michael Shenoda, Michael Shenoda, M.D., FACC, FSCAI

has no relevant financial relationships to disclose at this time.

Janet Wei

has no relevant financial relationships to disclose at this time.

NATHAN DONALD WONG, PhD, MPH, FACC, FAHA, FNLA, MASPC

has a financial relationship (Consultant) with Heart Lung;.
has a financial relationship (Consultant) with Amgen, Ionis, Novartis;.
has a financial relationship (Researcher) with Amgen, Ionis, Novartis;.

Richard Wong, Speaker

has no relevant financial relationships to disclose at this time.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and California Chapter, American College of Cardiology. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.ld only claim credit commensurate with the extent of their participation.

Available Credit

  • 8.00 ABIM Medical Knowledge
  • 8.00 AMA PRA Category 1 Credit
  • 8.00 Attendance

Price

Cost:
$0.00
Please login or register to take this course.